Post-Gardasil Syndrome: Raquel from Spain three years later By Norma Erickson, President The traditional media seems to overlook the fact that all of the victims of severe adverse reactions after HPV vaccines were originally trusting medical consumers who were simply following their doctor’s advice. They listened to the professionals when told that Gardsil or Cervarix […]
Three girls hospitalized after Cervarix HPV vaccine
By Norma Erickson 22 November 2011, an article appeared in a local newspaper in Spain reporting the cases of three girls suffering adverse reactions after Cervarix vaccinations. The original article, by Juan F. Robles, stated two of the three had been admitted to the local hospital for treatment of severe persistent headaches and tremors. Despite […]
Lucy Hinks, una joven británica de 13 años ha sufrido una encefalopatía miálgica después de recibir la vacuna del Papiloma Humano según publica el periódico británico The Telegraph. Los médicos creen que la causa del “coma despierto” que padece la joven es la citada vacuna.
AAVP Spain Valencia, 18 de noviembre 2011 by Alicia Capilla El caso de Lucy se suma al de otras muchísimas jóvenes que han sufrido y sufren los graves trastornos neurológicos que esta vacuna provoca y recuerda algunas de las muertes que se han relacionado directamente con la administración de esta vacuna. El […]
Spanish Press Neglects to Print Gardasil News
[Note from SaneVax: On 10 April 2011, the AAVP in Spain sent the following press release to their local newspaper. The SaneVax Team just got word today that the editor(s) obviously didn’t think the article was news-worthy and neglected to publish it. We disagree, particularly since medical authorities are using Gardasil® for older women, regardless […]
Gardasil doesn't guard against much in Spain
By Norma Erickson When Merck’s HPV (human papillomavirus) vaccine, Gardasil, was introduced in Andalucia, Spain in 2008, a full 58% of the 14-year old girls eligible to receive the series of three vaccinations did so, paid for by Spanish healthcare dollars. Two years later, after much controversy about potential side effects and efficacy issues that […]
